Frenova Renal Research announced that its F1RST Up alliance of clinical research sites focusing on kidney disease has expanded to include 55 physician investigators representing 23 sites.
The F1RST Up alliance membership includes nephrology practices, including end stage renal disease (ESRD) patients. F1RST Up investigators are clinical researchers in renal disease and its adjacencies, including vascular access and care, cardio-renal conditions, rare diseases, infectious diseases and transplant. The alliance leverages Frenova’s access to proprietary clinical research assets to inform protocol design and to carry out highly targeted and efficient patient recruitment efforts.
“We formed this alliance with the leading physician investigators from across Frenova’s network of 260 clinical research sites,” said Christina Kahn, Frenova’s F1RST Up alliance lead. “This is important because it means F1RST Up offers sponsors access to a uniquely concentrated source of both high quality renal research sites and a substantial number of patients.”